American Journal of Epidemiology Vol. 149, No. 10: 916-924
Copyright © 1999 by The Johns Hopkins University School of Hygiene and Public Health
other |
Epidemiology of Crohn's Disease and Ulcerative Colitis in a Central Canadian Province: A Population-based Study
1University of Manitoba Inflammatory Bowel Disease Clinical and Research Centre Winnipeg, Manitoba, Canada
2Epidemiology Unit, Manitoba Health Winnipeg, Manitoba, Canada
3Department of Community Health Sciences, University of Manitoba Winnipeg, Manitoba, Canad
Reprint requests to Dr. Charles N. Bernstein, Section of Gastroenterology, University of Manitoba, GB445-Health Sciences Centre, 820 Sherbrook St., Winnipeg, Manitoba, Canada R3A 1R9.
The aim of this study was to assess the accuracy and utility of administrative health data in identifying persons with inflammatory bowel disease on a population basis and to determine the incidence and prevalence of this disease in the Canadian province of Manitoba. The data from Manitoba Health (the province's single insurer) were used to identify residents with physician and/or hospital contacts for Crohn's disease or ulcerative colitis based on International Classification of Diseases, Ninth Revision, Clinical Modification, codes between 1984 and 1995. Of 5, 182 eligible individuals, 4,514 were mailed questionnaires and 2,725 responded. Cases were defined as individuals with five or more separate medical contacts with one of these diagnoses or three or more such contacts if they were resident for less than 2 years. The accuracy of the study case definitions was high when compared with either self-report or chart review. The 19891994 age- and sex-adjusted annual incidence was 14.6/100, 000 for Crohn's disease and 14.3/100, 000 for ulcerative colitis. The prevalence of Crohn's disease in 1994 was 198.5/100,000, and that of ulcerative colitis was 169.7/100,000. In conclusion, the authors have successfully established and validated a population-based database of inflammatory bowel disease based on administrative data. The high incidence rates and dynamic epidemiology of inflammatory bowel disease in Manitoba indicate the presence of important environmental risk factors, which warrants further investigation. Am J Epidemiol 1999; 149:91624.
colitis; ulcerative; Crohn disease; inflammatory bowel diseases
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
E I Benchimol, A Guttmann, A M Griffiths, L Rabeneck, D R Mack, H Brill, J Howard, J Guan, and T To Increasing incidence of paediatric inflammatory bowel disease in Ontario, Canada: evidence from health administrative data Gut, November 1, 2009; 58(11): 1490 - 1497. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Pittet, P. Juillerat, C. Mottet, C. Felley, P. Ballabeni, B. Burnand, P. Michetti, J.-P. Vader, and the Swiss IBD Cohort Study Group Cohort Profile: The Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS) Int. J. Epidemiol., August 1, 2009; 38(4): 922 - 931. [Full Text] [PDF] |
||||
![]() |
D. C. Mendelssohn, S. K. Mujais, S. D. Soroka, J. Brouillette, T. Takano, P. E. Barre, B. V. Mittal, A. Singh, C. Firanek, K. Story, et al. A prospective evaluation of renal replacement therapy modality eligibility Nephrol. Dial. Transplant., February 1, 2009; 24(2): 555 - 561. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. N. Bernstein, M.-H. Wang, M. Sargent, S. R. Brant, and M. T. Collins Testing the Interaction between NOD-2 Status and Serological Response to Mycobacterium paratuberculosis in Cases of Inflammatory Bowel Disease J. Clin. Microbiol., March 1, 2007; 45(3): 968 - 971. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Green, L. Elliott, C. Beaudoin, and C. N. Bernstein A Population-based Ecologic Study of Inflammatory Bowel Disease: Searching for Etiologic Clues Am. J. Epidemiol., October 1, 2006; 164(7): 615 - 623. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. D. Jaskowski, C. M. Litwin, and H. R. Hill Analysis of Serum Antibodies in Patients Suspected of Having Inflammatory Bowel Disease Clin. Vaccine Immunol., June 1, 2006; 13(6): 655 - 660. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Singh, D. Turner, L. Xue, L. E. Targownik, and C. N. Bernstein Risk of developing colorectal cancer following a negative colonoscopy examination: evidence for a 10-year interval between colonoscopies. JAMA, May 24, 2006; 295(20): 2366 - 2373. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Gasche and P Grundtner Genotypes and phenotypes in Crohn's disease: do they help in clinical management? Gut, January 1, 2005; 54(1): 162 - 167. [Full Text] [PDF] |
||||
![]() |
F Molinie, C Gower-Rousseau, T Yzet, V Merle, B Grandbastien, R Marti, E Lerebours, J-L Dupas, J-F Colombel, J-L Salomez, et al. Opposite evolution in incidence of Crohn's disease and ulcerative colitis in Northern France (1988-1999) Gut, June 1, 2004; 53(6): 843 - 848. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. N. Bernstein, J. F. Blanchard, P. Rawsthorne, and M. T. Collins Population-Based Case Control Study of Seroprevalence of Mycobacterium paratuberculosis in Patients with Crohn's Disease and Ulcerative Colitis J. Clin. Microbiol., March 1, 2004; 42(3): 1129 - 1135. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Carrie, C. J. Metge, D. M. Collins, G. K. M. Harding, and G. G. Zhanel Use of administrative healthcare claims to examine the effectiveness of trimethoprim-sulfamethoxazole versus fluoroquinolones in the treatment of community-acquired acute pyelonephritis in women J. Antimicrob. Chemother., March 1, 2004; 53(3): 512 - 517. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. N. Bernstein, G. Nayar, A. Hamel, and J. F. Blanchard Study of Animal-Borne Infections in the Mucosas of Patients with Inflammatory Bowel Disease and Population-Based Controls J. Clin. Microbiol., November 1, 2003; 41(11): 4986 - 4990. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y Ogura, S Lala, W Xin, E Smith, T A Dowds, F F Chen, E Zimmermann, M Tretiakova, J H Cho, J Hart, et al. Expression of NOD2 in Paneth cells: a possible link to Crohn's ileitis Gut, November 1, 2003; 52(11): 1591 - 1597. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Myles, R. S. Livingston, B. A. Livingston, J. M. Criley, and C. L. Franklin Analysis of Gene Expression in Ceca of Helicobacter hepaticus-Infected A/JCr Mice before and after Development of Typhlitis Infect. Immun., July 1, 2003; 71(7): 3885 - 3893. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Blanchard, C. N. Bernstein, A. Wajda, and P. Rawsthorne Small-area Variations and Sociodemographic Correlates for the Incidence of Crohn's Disease and Ulcerative Colitis Am. J. Epidemiol., August 15, 2001; 154(4): 328 - 335. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. N. Bernstein, J. F. Blanchard, W. Leslie, A. Wajda, and B. N. Yu The Incidence of Fracture among Patients with Inflammatory Bowel Disease: A Population-Based Cohort Study Ann Intern Med, November 21, 2000; 133(10): 795 - 799. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Broadley, J. Deans, S. J. Sawcer, D. Clayton, and D. A. S. Compston Autoimmune disease in first-degree relatives of patients with multiple sclerosis: A UK survey Brain, June 1, 2000; 123(6): 1102 - 1111. [Abstract] [Full Text] [PDF] |
||||
![]() |
E V Loftus Jr, M D Silverstein, W J Sandborn, W J Tremaine, W S Harmsen, and A R Zinsmeister Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival Gut, March 1, 2000; 46(3): 336 - 343. [Abstract] [Full Text] [PDF] |
||||










